Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode challenges traditional approaches and explores how innovation, systems thinking, and accountability can reshape how we achieve lasting cardiovascular health. Guest:Nihar R. Desai, MD, MPHAssociate Professor of MedicineYale School of MedicineVice Chief, Section of Cardiovascular MedicineYale New Haven Health SystemNew Haven, CT<a href='https://youtu.be/UkxRgeYWPV8'>Watch the Video</a>

<description>&lt;p&gt;Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode challenges traditional approaches and explores how innovation, systems thinking, and accountability can reshape how we achieve lasting cardiovascular health.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;Guest:&lt;/p&gt;&lt;p&gt;Nihar R. Desai, MD, MPH&lt;/p&gt;&lt;p&gt;Associate Professor of Medicine&lt;/p&gt;&lt;p&gt;Yale School of Medicine&lt;/p&gt;&lt;p&gt;Vice Chief, Section of Cardiovascular Medicine&lt;/p&gt;&lt;p&gt;Yale New Haven Health System&lt;/p&gt;&lt;p&gt;New Haven, CT&lt;/p&gt;&lt;p&gt;&lt;a href='https://youtu.be/UkxRgeYWPV8'&gt;Watch the Video&lt;/a&gt;&lt;/p&gt;</description>

Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode challenges traditional approaches and explores how innovation, systems thinking, and accountability can reshape how we achieve lasting cardiovascular health.   Guest: Nihar R. Desai, MD, MPH Associate Professor of Medicine Yale School of Medicine Vice Chief, Section of Cardiovascular Medicine Yale New Haven H...

S6E13: The Next Era of Prevention: Rethinking Cardiovascular Health from the Ground Up

In this episode of Lipid Insights, host Dr. Peter Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN Study and what it means for everyday lipid management. Together, they walk through the key questions clinicians ask when new evidence emerges: what the study set out to evaluate, how to interpret the findings in context, and where the results may (or may not) shift decision-making at the point of care. Dr. Bays brings a real-world lens to the conversation—highlighting how study design, patient selection, endpoints, and background therapy can influence how we apply data in practice. The episode emphasizes translating evidence into action, from identifying the right patients to aligning therapeutic strategy with risk, goals, and adherence realities. Whether you’re looking to sharpen your interpretation of clinical trial data or refine your approach to lipid-related risk reduction, this discussion offers clear takeaways you can use immediately. YouTube Link:<a href='https://youtu.be/s65WHd1WjII'>https://youtu.be/s65WHd1WjII</a>

<description>&lt;p&gt;In this episode of &lt;b&gt;Lipid Insights&lt;/b&gt;, host &lt;b&gt;Dr. Peter Jones&lt;/b&gt; is joined by &lt;b&gt;Dr. Harold Bays&lt;/b&gt; for a practical, clinician-focused discussion of the &lt;b&gt;ATTAIN Study&lt;/b&gt; and what it means for everyday lipid management. Together, they walk through the key questions clinicians ask when new evidence emerges: what the study set out to evaluate, how to interpret the findings in context, and where the results may (or may not) shift decision-making at the point of care.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;Dr. Bays brings a real-world lens to the conversation—highlighting how study design, patient selection, endpoints, and background therapy can influence how we apply data in practice. The episode emphasizes translating evidence into action, from identifying the right patients to aligning therapeutic strategy with risk, goals, and adherence realities. Whether you’re looking to sharpen your interpretation of clinical trial data or refine your approach to lipid-related risk reduction, this discussion offers clear takeaways you can use immediately.&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;YouTube Link:&lt;/p&gt;&lt;p&gt;&lt;a href='https://youtu.be/s65WHd1WjII'&gt;https://youtu.be/s65WHd1WjII&lt;/a&gt;&lt;/p&gt;</description>

In this episode of Lipid Insights, host Dr. Peter Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN Study and what it means for everyday lipid management. Together, they walk through the key questions clinicians ask when new evidence emerges: what the study set out to evaluate, how to interpret the findings in context, and where the results may (or may not) shift decision-making at the point of care.   Dr. Bays brings a real-world lens to the conve...

S6E12: ATTAIN in Practice: Translating Data Into Lipid Decisions

Join host Peter Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is joined by two leading pediatric experts—Don Wilson, MD, FNLA and Amy Shah, MD, FNLA—to explore practical strategies and emerging research on managing lipids and metabolic syndrome in younger populations.The discussion highlights key findings from their recently published special issue in the Journal of Clinical Lipidology, offering listeners evidence-based insights and clinical pearls to improve outcomes in pediatric and adolescent care. Whether you’re a clinician, researcher, or simply passionate about preventive cardiometabolic health, this episode delivers expert perspectives you won’t want to miss.

<description>&lt;p&gt;Join host &lt;b&gt;Peter Jones, MD, MNLA&lt;/b&gt; for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is joined by two leading pediatric experts—&lt;b&gt;Don Wilson, MD, FNLA&lt;/b&gt; and &lt;b&gt;Amy Shah, MD, FNLA&lt;/b&gt;—to explore practical strategies and emerging research on managing lipids and metabolic syndrome in younger populations.&lt;/p&gt;&lt;p&gt;The discussion highlights key findings from their recently published &lt;b&gt;special issue in the &lt;/b&gt;&lt;b&gt;&lt;em&gt;Journal of Clinical Lipidology&lt;/em&gt;&lt;/b&gt;, offering listeners evidence-based insights and clinical pearls to improve outcomes in pediatric and adolescent care. Whether you’re a clinician, researcher, or simply passionate about preventive cardiometabolic health, this episode delivers expert perspectives you won’t want to miss.&lt;/p&gt;</description>

Join host Peter Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is joined by two leading pediatric experts—Don Wilson, MD, FNLA and Amy Shah, MD, FNLA—to explore practical strategies and emerging research on managing lipids and metabolic syndrome in younger populations. The discussion highlights key findings from their recently published special issue in the Journal of Clinical Lipidology, offering listeners evidence-based ...

S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts

Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they will explore the integration of Lp(a) assessment into routine practice, implications for high-risk populations including those with familial hypercholesterolemia (FH), and strategies to mitigate cardiovascular risk until targeted therapies become available. Podcast Listeners can claim credit for this program by <a href='https://www.lipid.org/LipidInsights/s6e10accreditation'>Clicking Here</a>You can watch a video version of this podcast by <a href='https://youtu.be/l9OGZ_2u4Hk'>Clicking Here</a>

<description>&lt;p&gt;&lt;em&gt;Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;Hosted by Dr. Underberg, the &lt;em&gt;Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease &lt;/em&gt;podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they will explore the integration of Lp(a) assessment into routine practice, implications for high-risk populations including those with familial hypercholesterolemia (FH), and strategies to mitigate cardiovascular risk until targeted therapies become available. &lt;/p&gt;&lt;p&gt;Podcast Listeners can claim credit for this program by &lt;a href='https://www.lipid.org/LipidInsights/s6e10accreditation'&gt;&lt;b&gt;Clicking Here&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;You can watch a video version of this podcast by &lt;a href='https://youtu.be/l9OGZ_2u4Hk'&gt;&lt;b&gt;Clicking Here&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;</description>

Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease   Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they will explore the integration of Lp(a) assessment into routine practice, implications for high-...

S6E10: Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease

Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science. Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicine Philadelphia, PA Guest Alexis Baass, MD, MSc, FNLA Alexis Baass, MD, MSc, FNLA Director of the Lipids Nutrition and Cardiovascular Prevention Clinic Montreal Clinical Research Institute Montreal, QC, Canada<a href='https://youtu.be/zzCaDDkK20o'>Click here to see the video version of this episode</a>

<description>&lt;p&gt;Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science.&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Guest Host&lt;br/&gt;Daniel E. Soffer, MD, MNLA&lt;/b&gt;&lt;br/&gt;University of Pennsylvania Health System&lt;br/&gt;Internal Medicine/Clinical Lipidology&lt;br/&gt;Perelman Center for Advanced Medicine&lt;br/&gt;Philadelphia, PA&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Guest&lt;br/&gt;Alexis Baass, MD, MSc, FNLA Alexis Baass, MD, MSc, FNLA&lt;/b&gt;&lt;br/&gt;Director of the Lipids&lt;br/&gt;Nutrition and Cardiovascular Prevention Clinic&lt;br/&gt;Montreal Clinical Research Institute&lt;br/&gt;Montreal, QC, Canada&lt;/p&gt;&lt;p&gt;&lt;a href='https://youtu.be/zzCaDDkK20o'&gt;Click here to see the video version of this episode&lt;/a&gt;&lt;/p&gt;</description>

Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science.  Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicin...

S6 Lipid Snippet: Polygenic Risk Score for Coronary Artery Disease Predicts ASCVD in FH

Tune in to the NLA's podcast series to hear expert speakers discuss key topics in lipidology.&nbsp;

Lipid Insights

Details

Recent Episodes